LODER | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

9,108 results for “LODER”

Silexion's LODER Shows Promise in Non-Resectable Pancreatic Cancer

SIL-204 Demonstrates Synergy with Chemotherapy in KRAS-Driven Pancreatic Cancer Models

Silexion Therapeutics Receives Israeli Regulatory Approval for Phase 2/3 Trial of KRAS-Targeting RNAi Therapy SIL204

Semaglutide Associated with Reduced Alzheimer's Risk in Type 2 Diabetes Patients

Online Yoga Classes Effective for Chronic Low Back Pain Relief

Imetelstat Shows Durable Transfusion Independence in Lower-Risk MDS

Paxlovid's Efficacy Questioned in Lower-Risk COVID-19 Patients

FDA Approves First RSV Vaccine, Arexvy, for Older Adults

FDA Approves Moderna's mResvia RSV Vaccine for Older Adults

Semaglutide Linked to Reduced Alzheimer's Risk in Type 2 Diabetes Patients

Page 1 of 24